Nura Bio closed a $73.8 million Series B funding round. The financing will support the development of the company's pipeline of neuroprotective therapies. The round was led by Sanofi Ventures with participation from existing investors.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
Gero Raises $17M in New Funding